Tag archive for ‘Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)’
Niva Goldberg On Wednesday, March 18th, 2015

Ignyta acquires oncology assets from Teva

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), and Ignyta Inc. (Nasdaq: RXDX), announced the acquisition by Ignyta of the worldwide rights and assets relating to four targeted oncology development programs More...

HEALTH, PILL, TEVA, FINGERS
Jewish Business News On Sunday, March 9th, 2014

Teva Launches Xeloda Generic Cancer Drug

– According to IMS data Xeloda made by Genentech, had $754 million in US sales in 2013. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announces the launch of the generic equivalent More...

Teva Receives FDA Approval For Leukemia Treatment For Injection

– Synribo received provisional approval in 2012 subject to additional clinic trial data. – –  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the U.S. Food and More...

FDA Approves Teva’s New Formulation For Longer-lasting Copaxone

– – U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) new dose of COPAXONE drug application (sNDA) for three-times-a-week  40mg/mL. This new More...

Teva teams with Perrigo to launch Temodar brain tumor drug

– – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Perrigo Company (NYSE: PRGO;TASE) today announced the launch of the generic equivalent to Temodar (temozolomide). Teva will manufacture,  More...

Wordpress site Developed by Fixing WordPress Problems